List of Excipients in API olanzapine and fluoxetine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing olanzapine and fluoxetine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Eli Lilly and Company | SYMBYAX | olanzapine and fluoxetine hydrochloride | 0002-3230 | DIMETHICONE | |
| Eli Lilly and Company | SYMBYAX | olanzapine and fluoxetine hydrochloride | 0002-3230 | FERRIC OXIDE RED | |
| Eli Lilly and Company | SYMBYAX | olanzapine and fluoxetine hydrochloride | 0002-3230 | FERRIC OXIDE YELLOW | |
| Eli Lilly and Company | SYMBYAX | olanzapine and fluoxetine hydrochloride | 0002-3230 | GELATIN | |
| Eli Lilly and Company | SYMBYAX | olanzapine and fluoxetine hydrochloride | 0002-3230 | SODIUM LAURYL SULFATE | |
| Eli Lilly and Company | SYMBYAX | olanzapine and fluoxetine hydrochloride | 0002-3230 | STARCH, CORN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing olanzapine and fluoxetine
Detailed excipient profiles for olanzapine and fluoxetine
Excipient focus: D&C YELLOW NO. 10
olanzapine and fluoxetine drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
olanzapine and fluoxetine drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
olanzapine and fluoxetine drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
olanzapine and fluoxetine drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
olanzapine and fluoxetine drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
olanzapine and fluoxetine drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
olanzapine and fluoxetine drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
olanzapine and fluoxetine drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
olanzapine and fluoxetine drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
olanzapine and fluoxetine drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
olanzapine and fluoxetine drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
olanzapine and fluoxetine drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
olanzapine and fluoxetine drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: INDIGOTINDISULFONATE SODIUM
olanzapine and fluoxetine drug variants containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing INDIGOTINDISULFONATE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
olanzapine and fluoxetine drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
olanzapine and fluoxetine drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
olanzapine and fluoxetine drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
olanzapine and fluoxetine drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
olanzapine and fluoxetine drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
olanzapine and fluoxetine drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | olanzapine and fluoxetine | 0093-5503 |
| AvKARE | olanzapine and fluoxetine | 42291-652 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3230 |
| Eli Lilly and Company | olanzapine and fluoxetine hydrochloride | 0002-3231 |
| >Company | >Ingredient | >NDC |
olanzapine and fluoxetine drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
